Aerpio Pharmaceuticals OverviewAerpio Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ARPO.
Quarterly Other Income/Expense
$1.33M
↓ 98.49% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$6.90M
↓ 93.83% YoY
Trailing 12 months ending Mar 31, 2026